In trading on Tuesday, shares of Tekmira Pharmaceuticals Corp (TKMR) crossed below their last reported book value — defined as common shareholder equity per share — of $10.97, changing hands as low as $10.77 per share. Tekmira Pharmaceuticals Corp shares are currently trading off about 1.6% on the day. The chart below shows the one year performance of TKMR shares, versus its 50 and 200 day moving averages:Looking at the chart above, TKMR's low point in its 52 week range is $8.91 per share, with $29.93 as the 52 week high point — that compares with a last trade of $10.96. According to the ETF Finder at ETF Channel, TKMR makes up 1.82% of the Guru Index ETF ( GURU) which is trading lower by about 0.3% on the day Tuesday.
More from Stocks
Netflix, Japan Exports, TSMC Outlook, Musk and Brexit - 5 Things You Must Know
Netflix loses subscribers, Japan loses steam, Taiwan Semi bets on a chip-sector rebound, Britain stares down the abyss of a non-deal Brexit and Musk looks to your brain for his next startup fix.
Dow Futures Slip, Global Stocks Slide, as Tech Earnings, Trade Data Rattle Bulls
U.S. equity futures are pointing to a third day of declines on Wall Street Thursday as investors react to weaker-than-expected earnings in the tech and industrial sectors and signal increasing concern for the fate of U.S.-China trade talks.
Netflix's 'Troubling' Subscriber Miss Suggests It's Approaching a Price Ceiling
Netflix reported just 2.7 million new subscribers in the second quarter, which included a net loss of 130,000 in the U.S. Last quarter was the first time Netflix has lost domestic subscribers in the years it's been reporting streaming separately.